JinchengPharmaceuticalfocusesontechnologicalinnovationintheproduction,researchanddevelopment,andsalesofaseriesofproductswithsalicylicacidasthecoreAPI,intermediate,cosmetics,andchemicalrawmaterials.Thetotalassetsare306millionyuan,andthecompanyisproducing13varietiesofsalicylicacidseries.Thecompanycurrentlyhas12dedicatedproductionlines,4intermediatededicatedproductionlinesthatcomplywithISOstandards,withanannualtotaldesigncapacityofover20000tons,and8D-gradepurificationproductionlinesthatcomplywithGMPforactivepharmaceuticalingredients,withanannualdesigncapacityofover15000tons.
www.jqcpharm.com API接口 2025-07-10